AbbVie Selects Durham for New $1.4 Billion Manufacturing Campus

4월 23, 2026

AbbVie (NYSE: ABBV) announced a $1.4 billion investment to build a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina. The state-of-the-art campus will support the production of AbbVie’s immunology, neuroscience and oncology medicines. Durham was selected based on the strength of its local workforce and its ability to support future expansion. Construction will begin this year, with completion expected by the end of 2028.

Over the next four years, AbbVie plans to hire 734 people, including engineers, scientists, manufacturing operators and laboratory technicians. The project will also support the local economy by generating more than 2,000 construction jobs during campus development.